1. Home
  2. CMMB vs SWAG Comparison

CMMB vs SWAG Comparison

Compare CMMB & SWAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMMB
  • SWAG
  • Stock Information
  • Founded
  • CMMB 2004
  • SWAG 1994
  • Country
  • CMMB Israel
  • SWAG United States
  • Employees
  • CMMB N/A
  • SWAG N/A
  • Industry
  • CMMB Biotechnology: Pharmaceutical Preparations
  • SWAG Advertising
  • Sector
  • CMMB Health Care
  • SWAG Consumer Discretionary
  • Exchange
  • CMMB Nasdaq
  • SWAG Nasdaq
  • Market Cap
  • CMMB 23.6M
  • SWAG 20.1M
  • IPO Year
  • CMMB N/A
  • SWAG 2021
  • Fundamental
  • Price
  • CMMB $1.16
  • SWAG $1.01
  • Analyst Decision
  • CMMB Strong Buy
  • SWAG
  • Analyst Count
  • CMMB 2
  • SWAG 0
  • Target Price
  • CMMB $9.00
  • SWAG N/A
  • AVG Volume (30 Days)
  • CMMB 153.9K
  • SWAG 11.5K
  • Earning Date
  • CMMB 03-03-2025
  • SWAG 03-07-2025
  • Dividend Yield
  • CMMB N/A
  • SWAG N/A
  • EPS Growth
  • CMMB N/A
  • SWAG N/A
  • EPS
  • CMMB N/A
  • SWAG N/A
  • Revenue
  • CMMB N/A
  • SWAG $78,604,000.00
  • Revenue This Year
  • CMMB N/A
  • SWAG $11.39
  • Revenue Next Year
  • CMMB N/A
  • SWAG N/A
  • P/E Ratio
  • CMMB N/A
  • SWAG N/A
  • Revenue Growth
  • CMMB N/A
  • SWAG 11.82
  • 52 Week Low
  • CMMB $0.58
  • SWAG $0.73
  • 52 Week High
  • CMMB $2.55
  • SWAG $1.52
  • Technical
  • Relative Strength Index (RSI)
  • CMMB 31.89
  • SWAG 47.71
  • Support Level
  • CMMB $0.92
  • SWAG $0.90
  • Resistance Level
  • CMMB $1.35
  • SWAG $1.05
  • Average True Range (ATR)
  • CMMB 0.12
  • SWAG 0.09
  • MACD
  • CMMB -0.01
  • SWAG 0.01
  • Stochastic Oscillator
  • CMMB 24.79
  • SWAG 26.24

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

About SWAG Stran & Company Inc.

Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, It offer its clients with custom sourcing capabilities which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, and event assets, order and inventory management, and designing and hosting online retail popup shops. The company purchases products and branding through various third-party manufacturers and decorators and resells the finished goods to customers.

Share on Social Networks: